Kent, United Kingdom

Alan David Jones

This inventor holds 1 USPTO granted patent. Top assignee: Smithkline Beecham Corporation. Active years: 2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alan David Jones. Retrieved from https://idiyas.com/inventor/alan-david-jones

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Alan David Jones: Innovator in Pharmaceutical Chemistry

Introduction

Alan David Jones is a notable inventor based in Kent, GB. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on paroxetine derivatives.

Latest Patents

Jones holds a patent for paroxetine derivatives, specifically focusing on piperidine compounds. His patent details processes for preparing these compounds, pharmaceutical compositions that include them, and their therapeutic uses. This invention showcases his expertise in developing new pharmaceutical solutions.

Career Highlights

Alan David Jones is associated with SmithKline Beecham Corporation, where he has been instrumental in advancing research and development in pharmaceuticals. His work has contributed to the company's reputation as a leader in the industry.

Collaborations

Throughout his career, Jones has collaborated with esteemed colleagues, including Andrew Simon Craig and Deirdre O'Keeffe. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Alan David Jones exemplifies the spirit of innovation in the pharmaceutical industry through his patented work and collaborations. His contributions continue to impact therapeutic advancements and improve patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…